| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 51.038.701 $ | 99,22 | 5.045.422 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 8.280.689 $ | 16,10 | 9.003 | |
| Novo Nordisk A/S | Novo Nordisk A/S | EC | 670100205 | Long | Börsenkurs (Stufe 1) | 6.755.900 $ | 13,13 | 183.834 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 3.886.806 $ | 7,56 | 138.419 | |
| Viking Therapeutics Inc | Viking Therapeutics Inc | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 2.719.335 $ | 5,29 | 83.569 | |
| Innovent Biologics Inc | Innovent Biologics Inc | EC | KYG4818G1010 | Long | Börsenkurs (Stufe 1) | 2.625.985 $ | 5,11 | 242.500 | |
| Ascletis Pharma Inc | Ascletis Pharma Inc | EC | KYG0520K1094 | Long | Börsenkurs (Stufe 1) | 2.404.673 $ | 4,67 | 1.133.000 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 2.027.360 $ | 3,94 | 5.762 | |
| Roche Holding AG | Roche Holding AG | EC | CH1499059983 | Long | Börsenkurs (Stufe 1) | 2.015.365 $ | 3,92 | 5.146 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 1.936.503 $ | 3,76 | 9.819 | |
| Hanmi Pharm Co Ltd | Hanmi Pharm Co Ltd | EC | KR7128940004 | Long | Börsenkurs (Stufe 1) | 1.880.583 $ | 3,66 | 5.593 | |
| Zealand Pharma A/S | Zealand Pharma A/S | EC | DK0060257814 | Long | Börsenkurs (Stufe 1) | 1.850.630 $ | 3,60 | 40.685 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 1.775.352 $ | 3,45 | 32.800 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.713.716 $ | 3,33 | 2.218 | |
| FOSUN PHARMA | Shanghai Fosun Pharmaceutical Group Co Ltd | EC | CNE100001M79 | Long | Börsenkurs (Stufe 1) | 1.674.798 $ | 3,26 | 662.500 | |
| CSPC Pharmaceutical Group Ltd | CSPC Pharmaceutical Group Ltd | EC | HK1093012172 | Long | Börsenkurs (Stufe 1) | 1.506.569 $ | 2,93 | 1.298.000 | |
| Gubra A/S | Gubra A/S | EC | DK0062266474 | Long | Börsenkurs (Stufe 1) | 1.243.819 $ | 2,42 | 22.723 | |
| Structure Therapeutics Inc | Structure Therapeutics Inc | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 1.223.220 $ | 2,38 | 25.378 | |
| UNITED LAB | United Laboratories International Holdings Ltd/The | EC | KYG8813K1085 | Long | Börsenkurs (Stufe 1) | 1.169.350 $ | 2,27 | 954.000 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 1.022.780 $ | 1,99 | 34.264 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 981.583 $ | 1,91 | 7.043 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 736.027 $ | 1,43 | 8.463 | |
| Shionogi & Co Ltd | Shionogi & Co Ltd | EC | JP3347200002 | Long | Börsenkurs (Stufe 1) | 713.032 $ | 1,39 | 32.700 | |
| Biohaven Ltd | Biohaven Ltd | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 449.175 $ | 0,87 | 53.094 | |
| WaVe Life Sciences Ltd | WaVe Life Sciences Ltd | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 237.641 $ | 0,46 | 32.778 | |
| Corbus Pharmaceuticals Holding | Corbus Pharmaceuticals Holdings Inc | EC | 21833P301 | Long | Börsenkurs (Stufe 1) | 207.810 $ | 0,40 | 22.131 | |
| 51.038.701 $ | 99,22 | 5.045.422 |